Exagen, Inc. (XGN)
3.41
+0.14
(+4.28%)
USD |
NASDAQ |
Feb 20, 16:00
3.415
0.00 (0.00%)
After-Hours: 20:00
Exagen EPS Diluted (Quarterly) : -0.3089 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.0329 |
| Thermo Fisher Scientific, Inc. | 5.21 |
| XWELL, Inc. | -0.2557 |
| Hypha Labs, Inc. | -0.0034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.087M |
| Revenue (Quarterly) | 17.24M |
| Total Expenses (Quarterly) | 24.33M |
| Enterprise Value | 69.80M |
| Gross Profit Margin (Quarterly) | 58.43% |
| Profit Margin (Quarterly) | -41.10% |
| Earnings Yield | -27.15% |
| Normalized Earnings Yield | -24.04 |